Hercules Capital is the lender. Rocket received $35 million at closing, reported no revenue in 2025 or 2024, and held $283.7 million in cash and investments at June 30, 2026.
Rocket Pharmaceuticals received $35 million at closing under a credit facility of up to $150 million with Hercules Capital. The company expects its cash, with that first draw, to fund operations into the third quarter of 2028, and it says more borrowing could extend that into 2029.
Questions about Hercules Capital
What is the ticker symbol of Hercules Capital?
Hercules Capital, Inc. trades under the ticker HTGC on NYSE.
Where is Hercules Capital listed?
Hercules Capital, Inc. is listed on NYSE.
Which country or territory is Hercules Capital listed under?
Our directory records Hercules Capital, Inc. under Not recorded.
Does aibio.space cover Hercules Capital?
aibio.space lists Hercules Capital, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Which other companies' news mentions Hercules Capital?
Hercules Capital is named in 2 of our stories about other companies, most recently: "Rocket Pharmaceuticals secures credit facility of up to $150 million" (Oct 6, 2026); "Rocket Pharmaceuticals secures credit facility of up to $150 million from Hercules" (Oct 6, 2026). Source.
How can I follow Hercules Capital (HTGC) news?
Press Follow on this page to add Hercules Capital to your Following list, or subscribe to the aibio.space newsletter. We have published 2 stories naming Hercules Capital so far, in Debt Financing.
Investor discussion: Hercules Capital
Members talk about Hercules Capital (HTGC). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Stock chart
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NYSE:HTGC on TradingView.
Listing details
Hercules Capital, Inc. is a public biotech or pharmaceutical company listed on NYSE under the ticker HTGC, recorded under Not recorded. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Company
Hercules Capital, Inc.
Ticker
HTGC
Listing
NYSE
Country or territory
Not recorded
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio